A n extensive body of research has reported that women experience worse outcomes compared with men when the full spectrum of acute coronary syndromes (ACS) are included (1-4). Compared with men, women are more likely to experience major bleeding (1,2) and vascular access complications (2) post-percutaneous coronary intervention, as well as a higher rate of major adverse cardiovascular events (1) and death (4) within 1 year post-ACS and beyond. Although the "high-risk" profile of women is well established, the degree to which this disparity is explained by differences in age and comorbidities remains an area of debate (1,3). This picture is complicated by the observation that the risk associated with female sex may differ by age strata and ACS subtype. An age-sex interaction has been described (4) whereby younger women, but not older women, experience worse outcomes than their age-matched male counterparts. In addition, a sex-ACS subtype interaction was found in a large sample of clinical trial participants (5) 
A n extensive body of research has reported that women experience worse outcomes compared with men when the full spectrum of acute coronary syndromes (ACS) are included (1) (2) (3) (4) . Compared with men, women are more likely to experience major bleeding (1, 2) and vascular access complications (2) post-percutaneous coronary intervention, as well as a higher rate of major adverse cardiovascular events (1) and death (4) within 1 year post-ACS and beyond. Although the "high-risk" profile of women is well established, the degree to which this disparity is explained by differences in age and comorbidities remains an area of debate (1, 3) . This picture is complicated by the observation that the risk associated with female sex may differ by age strata and ACS subtype. An age-sex interaction has been described (4) whereby younger women, but not older women, experience worse outcomes than their age-matched male counterparts. In addition, a sex-ACS subtype interaction was found in a large sample of clinical trial participants (5), whereby women with ST-segment elevation acute coronary syndromes (STEACS) fared worse, and women with non-ST-segment elevation acute coronary syndromes (NSTEACS) fared better, than men with similar clinical presentations.
Changing demographics have created an imperative to study outcomes in older adults with ACS, and understanding differences between older women and older men undergoing revascularization is one important area for exploration. To date, comparative effectiveness studies are limited because both women (3, 6) and older adults (age $75 years) (6) have been historically underrepresented in ACS clinical trials. Among ACS subtypes in older adults, NSTEACS is more common than STEACS (7) , and a key question among older NSTEACS patients involves whether routine early invasive management is warranted. The mean patient age was only 62 years in a meta-analysis of 7 studies that demonstrated that routine early invasive management for high-risk NSTEACS reduced rates of death or reinfarction, over a mean follow-up of 17 months (8) .
One particular topic of uncertainty concerning older adults with NSTEACS centers on whether older women benefit less than older men from an early invasive approach (9) . Observational studies of older authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Elderly ACS study, which pooled data from NSTEACS patients age $75 years enrolled across 23 centers.
Patients the rate of major bleeding with radial access for NSTEACS (n ¼ 2,552) was 1.8%, in a population whose mean age was 63 years (13) . Site-specific attention to management of anticoagulant or antiplatelet agents, or other factors such as a healthier than average population, may account for the very low observed bleeding rate. Nonetheless, it is unclear whether these results apply to more "typical" older adults with ACS in practice and when systematic complete capture of events is ensured. It is also worthy of mention that women in the current study underwent invasive angiography at the same rate as men but were revascularized less, which suggests that anatomic differences between the groups (e.g., higher rate of chronic total occlusions, distal vessel disease, or nonobstructive disease) were a factor in decision making.
In conclusion, robust previous data demonstrate 
